USVP

U.S. Venture Partners (USVP) is a prominent venture capital partnership dedicated to assisting entrepreneurs in turning their innovative ideas into impactful companies. With over thirty years of experience, the firm specializes in early-stage investments primarily within the information technology and healthcare sectors. USVP's investment focus includes enterprise software, IT security, consumer internet, mobile applications, e-commerce, and IT-enabled healthcare services. The team at USVP comprises former entrepreneurs, technologists, corporate leaders, financial experts, and industry specialists, all committed to fostering innovation that generates economic growth and job creation.

Jacques Benkoski

General Partner

Matthew Garratt

General Partner

Dale Holladay

CFO

Steven M. Krausz

General Partner

Rick Lewis

General Partner

Jon Root

General Partner

Casey Tansey

General Partner

Dafina Toncheva

General Partner

557 past transactions

Surgical Safety Technologies delivers data-driven AI technology to hospitals for safe surgeries. It empowers surgeons with an objective assessment of technical and non-technical proficiency using academically validated frameworks.

TaskHuman

Series B in 2022
You go to a network of doctors for medical problems, but where do you go for wellness and self-care? Your wellness needs are just as unique as YOU are. Whether you are just a curious person and want to learn something new (Ex: Try Pilates for the first time) or want to master your craft (Train for a marathon at a high level), why waste time reading cookie-cutter articles and watching generic videos when you can talk live to a human expert in that area? Well, because even mighty Google hasn't made it that easy to find and engage instantly with live human pros!!. Introducing TaskHuman - With TaskHuman, you just search a topic (ex yoga, or HIIT or Clean Eating) and get connected instantly to live professionals over video call. You'll stay accountable, motivated and focused on your wellness goals all while saving time, commuting miles and cash. - On TaskHuman, every session is with a live human coach and 1-on-1 over video call, leading to a richer and more personalized experience, as opposed to other platforms that only offer generic content, pre-recorded videos and text-only communication.Or if you are shy or video call is simply not your thing, choose audio call or text instead. - Try a 1:1 yoga session with a yoga master or get personalized clean eating advice from top holistic health coaches. From just your phone or tablet!! - We've build in state-of-the-art artificial intelligence (AI) to instantly match you with our providers that are online and available NOW. - We also have the most diverse network of hundreds of coaches covering a thousand topics across the wellness spectrum—including physical fitness, mental wellbeing, relationship coaching, life coaching, and so much more. - With a revolutionary pricing model, all coaches are covered under one simple pricing model for you. Just buy coaching minutes you need and use the minutes on ANY provider in our platform. Its that easy! - Enterprise deployments with unlimited coaching minutes available as well!

MicroTransponder

Series E in 2022
MicroTransponder, Inc. is a medical device company focused on developing and commercializing neurostimulation devices aimed at treating neurological diseases. The company offers innovative therapies, including the Serenity System for tinnitus and the Paired VNS System, which addresses chronic pain and post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas, and aims to enhance treatment options for various neurological conditions through its advanced technology.

nfinite

Series B in 2022
nfinite is a Paris-based company founded in 2016 that operates a web platform connecting homeowners, architects, and designers to facilitate home customization. The platform leverages artificial intelligence and proprietary 3D technology to enhance the visual experience for online home and living businesses. In addition to customization services, nfinite also offers a range of products for sale, aiming to streamline the process of designing and purchasing homes.

Carlsmed

Series B in 2022
Carlsmed, founded in 2018 and based in San Diego, California, develops a platform that integrates clinical intelligence, advanced image recognition, and 3D printing technologies specifically for spine surgery. The company's proprietary Aprevo platform utilizes artificial intelligence and predictive analytics to personalize treatment plans for complex spinal deformities, drawing on prior outcomes data to enhance surgical precision. By providing surgeons with tailored surgical plans and devices, Carlsmed aims to improve patient outcomes while reducing healthcare costs associated with complex spine surgeries. The company is dedicated to transforming healthcare and enabling adults to regain active lifestyles through innovative solutions in spinal care.

IONIX

Series A in 2022
IONIX is an Israeli cybersecurity company founded in 2016, based in Tel Aviv. The company develops an ecosystem security platform designed to help organizations identify and mitigate threats associated with their online assets, which include websites and cloud services. Its primary product, HackerPOV, provides advanced security monitoring and mapping of assets, enabling users to analyze and audit their web, cloud, and DNS infrastructures. IONIX's solutions focus on discovering vulnerabilities, assessing risks, and offering protection against malicious activities originating from users and third parties. The platform also monitors changes that may impact security and provides detailed alerts and active protection to secure organizational assets effectively.

Kryptowire

Venture Round in 2022
Kryptowire was jumpstarted by the Defense Advanced Research Projects Agency (DARPA) and the Department of Homeland Security (DHS S&T), and has been vetted by the US military, law enforcement, and intelligence agencies. Kryptowire provides mobile application security analysis tools, anti‐piracy technologies, mobile app marketplace security analytics, and Enterprise Mobility Management (EMM) solutions. Kryptowire was founded in 2011, is based in Fairfax, Virginia, and has a customer base ranging from government agencies to national cable TV companies.

nfinite

Series A in 2022
nfinite is a Paris-based company founded in 2016 that operates a web platform connecting homeowners, architects, and designers to facilitate home customization. The platform leverages artificial intelligence and proprietary 3D technology to enhance the visual experience for online home and living businesses. In addition to customization services, nfinite also offers a range of products for sale, aiming to streamline the process of designing and purchasing homes.

Hunters

Series C in 2022
Cyber Hunters Ltd. develops an artificial intelligence (AI) based software solution for the detection of cyber attack. The company offers a platform, Hunters.AI, which provides detection, prevention, and autonomous hunting cyber threats and breaches. It connects the digital traces to generate actionable visualized attack stories, and optimizes response time. The company was founded in 2018 and is headquartered in Tel Aviv, Israel.

Qnovo

Series C in 2022
Qnovo fundamentally improves the consumer mobile experience by re-imagining one of the most basic foundations of mobility – the battery and how it is charged. Qnovo improves mobile device battery performance with patented adaptive fast charging algorithms to produce tangible consumer, carrier and mobile OEM benefits – thinner devices, faster charging, increased daily runtime, longer battery lifetime as well as lower cost batteries and reduced return costs.

Route 92

Series E in 2021
Route 92 Medical, Inc. specializes in developing innovative medical devices aimed at treating acute ischemic stroke and related conditions. The company has created a stealthy catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery system. These products are designed to assist healthcare professionals in effectively treating strokes and enhancing patient recovery. Founded in 2015 and based in San Mateo, California, Route 92 Medical continues to focus on advancing technologies that improve outcomes for stroke patients.

TaskHuman

Series A in 2021
You go to a network of doctors for medical problems, but where do you go for wellness and self-care? Your wellness needs are just as unique as YOU are. Whether you are just a curious person and want to learn something new (Ex: Try Pilates for the first time) or want to master your craft (Train for a marathon at a high level), why waste time reading cookie-cutter articles and watching generic videos when you can talk live to a human expert in that area? Well, because even mighty Google hasn't made it that easy to find and engage instantly with live human pros!!. Introducing TaskHuman - With TaskHuman, you just search a topic (ex yoga, or HIIT or Clean Eating) and get connected instantly to live professionals over video call. You'll stay accountable, motivated and focused on your wellness goals all while saving time, commuting miles and cash. - On TaskHuman, every session is with a live human coach and 1-on-1 over video call, leading to a richer and more personalized experience, as opposed to other platforms that only offer generic content, pre-recorded videos and text-only communication.Or if you are shy or video call is simply not your thing, choose audio call or text instead. - Try a 1:1 yoga session with a yoga master or get personalized clean eating advice from top holistic health coaches. From just your phone or tablet!! - We've build in state-of-the-art artificial intelligence (AI) to instantly match you with our providers that are online and available NOW. - We also have the most diverse network of hundreds of coaches covering a thousand topics across the wellness spectrum—including physical fitness, mental wellbeing, relationship coaching, life coaching, and so much more. - With a revolutionary pricing model, all coaches are covered under one simple pricing model for you. Just buy coaching minutes you need and use the minutes on ANY provider in our platform. Its that easy! - Enterprise deployments with unlimited coaching minutes available as well!

Luma Health

Series C in 2021
Luma Health Inc. is a San Francisco-based company founded in 2015 that specializes in developing a patient engagement platform designed to enhance the connection between patients and healthcare providers. The platform facilitates smart scheduling, referral management, and appointment reminders, as well as mobile patient intake and care pathways. It also supports patient communications and integrates with electronic health records (EHR) while providing insights and analytics. By focusing on modern, mobile-first solutions, Luma Health aims to improve the patient experience and optimize appointment utilization for healthcare providers and health systems.
Effector Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2012. The company specializes in the discovery and development of small molecule drugs designed to treat cancer and other serious diseases by selectively regulating protein synthesis, specifically targeting mRNA translation. Effector Therapeutics focuses on developing translation regulators that inhibit disregulated translation, which is crucial for tumor growth and survival. This innovative approach aims to provide potent and selective therapeutic options, offering a promising avenue for delivering new cancer treatments to patients in need.

Hunters

Series B in 2021
Cyber Hunters Ltd. develops an artificial intelligence (AI) based software solution for the detection of cyber attack. The company offers a platform, Hunters.AI, which provides detection, prevention, and autonomous hunting cyber threats and breaches. It connects the digital traces to generate actionable visualized attack stories, and optimizes response time. The company was founded in 2018 and is headquartered in Tel Aviv, Israel.

Carrot Fertility

Series C in 2021
Carrot offers a fertility benefit for modern companies, focused on making fertility care easier, accessible, and more affordable. The company partners with modern companies to provide fertility coverage for the millions of employees. Through its software, Carrot helps employees to personalize a fertility plan, chat with fertility experts, order medications, and access unique content. It helps them access the care they need, such as egg freezing, in-vitro fertilization, fertility diagnoses, and more.

Human Interest

Series D in 2021
Human Interest offers easy and affordable employee retirement plans. Previously, only large companies offered employee retirement plans, leaving more than half of all working Americans without a path to a secure financial future. The company believes that a path to financial independence should be accessible to people in all lines of work.

Ribon Therapeutics

Series C in 2021
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.

Standard Bariatrics

Series B in 2021
Standard Bariatrics is a medical device company based in Cincinnati, Ohio, founded in 2014. The company specializes in the development of surgical instruments designed for weight loss surgeries, particularly laparoscopic sleeve gastrectomy. One of its key products is the Standard Clamp, which assists surgeons in standardizing their techniques to minimize variation, enhance efficiency, and reduce waste during procedures. Additionally, the company's disposable surgical tools complement general-use endoscopic staplers, allowing surgeons to decrease the number of cartridges used in surgeries and ultimately lowering costs. Through these innovations, Standard Bariatrics aims to improve surgical outcomes and streamline the weight loss surgery process.

Oliver Space

Series A in 2021
Oliver Space is a home furnishing company that makes beautiful spaces easy and affordable. The company was founded in 2019 and is based in San Francisco, California.

Sparrow Pharmaceuticals

Series A in 2021
Sparrow Pharmaceuticals, founded in 2013 and based in Portland, Oregon, focuses on developing targeted therapies for conditions related to corticosteroid excess. The company aims to provide innovative treatment options for disorders linked to elevated levels of cortisol, which can arise from tumors or prolonged use of corticosteroid medications like prednisone. By addressing serious issues associated with hypercortisolism, Sparrow Pharmaceuticals seeks to enhance the management of autoimmune and inflammatory conditions, ultimately improving patient care and outcomes in this challenging medical area.

Informed

Series A in 2021
Informed helps banks accelerate their digital transformation with turn-key robotic process automation capable of performing real-time income verification, identity verification, residence verification, and insurance verification tasks. Banks use Informed to reduce their manual costs associated with reviewing documents, catch fraud, and cut down on errors when originating loans and opening accounts.

Territory Foods

Series B in 2021
Territory Foods is a chef-prepared meal delivery service that creates nutritionist-approved menus tailored to support various dietary preferences and regional market tastes. Its fresh, healthy, ready-to-eat meals are designed by in-house culinary professionals and nutrition experts, prepared by a dedicated team of chefs, and powered by a proprietary algorithm that informs personalized menu variety at scale. Its boredom-proof rotating menus feature a wide variety of freshly-made artisan meals per week that are responsibly sourced, always free of refined sugars, and made without ingredients that contain gluten and dairy. Menus can be customized to meet dietary templates such as Vegan, Vegetarian, Whole30, and Keto, taking the guesswork out of navigating and committing to healthy eating. Territory Foods launched in 2011 and is headquartered in Arlington, VA.

Dapper Labs

Venture Round in 2021
Dapper Labs Inc. develops blockchain-based cryptokitties video games. The company offers consumer blockchain collectible cats games for entertainment brands. Dapper Labs Inc. was incorporated in 2018 and is based in Vancouver, Canada.

Act-On Software

Venture Round in 2021
Act-On Software, Inc. develops a cloud-based marketing automation platform designed for small and mid-sized businesses. This platform enables marketers to manage various aspects of their marketing efforts, including email campaigns, lead generation, social media marketing, and analytics, all from a single dashboard. Act-On's solutions facilitate the creation of effective marketing campaigns that attract and convert leads, while also allowing for personalized web experiences. The company also provides professional consulting, support, and training services to enhance users' marketing capabilities. Act-On serves a diverse range of industries, including banking, insurance, technology, and manufacturing. Founded in 2006 and based in Portland, Oregon, with additional offices in Scottsdale, Arizona, and Reading, United Kingdom, Act-On was previously known as On-Demand Software, Inc. before its rebranding in 2006.

Neuros Medical

Series B in 2021
Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies to address unmet medical needs for patients globally. The company’s flagship technology, Electrical Nerve Block, targets the elimination of chronic pain associated with various conditions, including neuroma, residual limb pain, chronic post-surgical pain, and chronic migraines. Additionally, Neuros Medical offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices designed to enhance treatment outcomes. Founded in 2008, the company aims to provide innovative solutions for chronic pain management.

Carlsmed

Series A in 2020
Carlsmed, founded in 2018 and based in San Diego, California, develops a platform that integrates clinical intelligence, advanced image recognition, and 3D printing technologies specifically for spine surgery. The company's proprietary Aprevo platform utilizes artificial intelligence and predictive analytics to personalize treatment plans for complex spinal deformities, drawing on prior outcomes data to enhance surgical precision. By providing surgeons with tailored surgical plans and devices, Carlsmed aims to improve patient outcomes while reducing healthcare costs associated with complex spine surgeries. The company is dedicated to transforming healthcare and enabling adults to regain active lifestyles through innovative solutions in spinal care.

Edgewise Therapeutics

Series C in 2020
Edgewise Therapeutics is a clinical-stage biopharmaceutical company based in Boulder, Colorado, specializing in the development of small molecule therapies for severe musculoskeletal diseases. Founded in 2017, the company leverages its expertise in skeletal muscle physiology to create innovative treatments for genetically defined muscle disorders, including Duchenne, Becker, and limb girdle muscular dystrophies. Edgewise Therapeutics employs a precision medicine platform to identify and target key muscle proteins and modulators, aiming to address the underlying causes of these conditions. Additionally, the company has established a state-of-the-art research facility to enhance its capabilities in understanding muscle adaptation and injury related to disease.

Percepto

Series B in 2020
Percepto is a developer of autonomous drone technology for inspection and surveillance. Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier to making them a must-have platform is the ability of drones to perform tasks autonomously. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Stensul

Series B in 2020
Stensul, Inc. is a New York-based company that offers a hosted Software-as-a-Service (SaaS) email creation platform designed for enterprises and large organizations globally. Founded in 2016, the platform enables users to efficiently create and deliver mobile-responsive emails for various purposes, such as email-based customer relationship management and marketing automation. By streamlining the email creation process and reducing the reliance on designers and developers, Stensul allows marketers to concentrate on producing engaging content that drives results. The platform is centralized, scalable, and tailored to individual brands, facilitating the quick generation of emails that can be sent directly through users' existing email service providers or marketing clouds.

Shoulder Innovations

Venture Round in 2020
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, established in 2009. It specializes in designing and manufacturing orthopedic solutions specifically for shoulder replacement surgeries. The company's flagship product, the Total Shoulder Replacement System, features an innovative inset glenoid fixation technology, which enhances the stability and reliability of the glenoid implant—a critical factor in shoulder arthroplasty. This system aims to address the major challenge of implant fixation, which can lead to complications and the need for revision surgeries. Additionally, Shoulder Innovations provides the necessary surgical instrumentation that simplifies the implantation process, ultimately reducing operative time and costs. The company markets its products through distribution partners across the United States, focusing on improving patient outcomes and lowering overall healthcare expenses.

Silverback Therapeutics

Series C in 2020
Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing tissue-targeted therapeutics for cancer, chronic viral infections, and other serious diseases. The company's lead product candidate, SBT6050, is currently in a Phase I/Ib clinical trial. It is a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody, specifically targeting tumors such as breast, gastric, and non-small cell lung cancers. Additionally, Silverback is advancing SBT6290, a preclinical candidate that targets Nectin4, expressed in various cancers, and SBT8230, aimed at treating chronic hepatitis B virus infection. Utilizing its proprietary ImmunoTAC technology, Silverback aims to develop a new generation of therapies that can be systemically delivered yet act locally at disease sites, thereby modulating critical disease pathways that were previously considered inaccessible.

Medigate

Series B in 2020
Medigate owns and operates a medical device security platform that protects all connected medical devices on health care provider networks. The platform offers threat detection and attack prevention services. Itay Kirshenbaum, Jonathan Langer, and Pini Pinhasov founded Medigate on September 1, 2017. It has its headquarters in New York City.

Optimize Health

Series A in 2020
Optimize.health is a provider of a digital healthcare platform that enables the deployment of Remote Patient Monitoring (RPM) programs. It uses easy-to-use equipment and software. The software is designed to facilitate provider compliance when billing to new Medicare CPT codes for RPM while providing a great user experience for both patients and providers. Its system is designed to be profitable for physicians starting in the first month. Chuks Onwuneme, Jeff LeBrun, and Otto Sipe established the company in Seattle, Washington in 2015.

Carrot Fertility

Series B in 2020
Carrot offers a fertility benefit for modern companies, focused on making fertility care easier, accessible, and more affordable. The company partners with modern companies to provide fertility coverage for the millions of employees. Through its software, Carrot helps employees to personalize a fertility plan, chat with fertility experts, order medications, and access unique content. It helps them access the care they need, such as egg freezing, in-vitro fertilization, fertility diagnoses, and more.

Hunters

Series A in 2020
Cyber Hunters Ltd. develops an artificial intelligence (AI) based software solution for the detection of cyber attack. The company offers a platform, Hunters.AI, which provides detection, prevention, and autonomous hunting cyber threats and breaches. It connects the digital traces to generate actionable visualized attack stories, and optimizes response time. The company was founded in 2018 and is headquartered in Tel Aviv, Israel.

Okami Medical

Series D in 2020
Okami Medical, Inc. specializes in the manufacturing and supply of medical devices designed for the occlusion of peripheral vessels. The company's flagship product, the LOw-profile Braided Occluder (LOBO), provides interventional physicians with a versatile solution for occluding various arterial targets without the need for multiple embolic devices. The LOBO system features a patented design and proprietary HDBRAID technology, which creates a highly occlusive pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011 and headquartered in Aliso Viejo, California, Okami Medical was established to meet the evolving needs of patients and physicians by developing innovative and reliable medical devices for vessel occlusion.

Zerto

Series F in 2020
Zerto provides business continuity software solutions to keep enterprise and cloud IT running 24/7. Through the Zerto Cloud Continuity Platform, organizations can protect and move virtualized workloads between public, private and hybrid clouds. Its flagship product, Zerto Virtual Replication, allows users to protect, recover and migrate applications in cloud and virtualized data centers.

Cato Networks

Series D in 2020
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform designed for modern enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in multiple global locations, the company offers an integrated networking and security solution that connects enterprise locations, users, and data securely. Cato's platform includes features such as WAN optimization, firewall protection, secure web gateways, threat protection, and unified communications optimization. It facilitates secure remote access, last mile management, and site deployment, catering to the needs of distributed, mobile, and cloud-enabled organizations. By eliminating traditional branch appliances and reducing MPLS costs, Cato Networks enhances performance across global locations and cloud applications, ensuring secure internet access for users everywhere.

Forager

Series A in 2020
Forager Group, Inc. is a company that specializes in cross-border freight and logistics services, primarily catering to supply chain networks in the automotive and aerospace sectors. Established in 2018 and headquartered in Chicago, Illinois, Forager offers a range of services, including standard, expedited, and cross-border truckload solutions. The company utilizes advanced technology to address the challenges faced by cross-border shippers, providing modern and efficient transportation solutions. Additionally, Forager features a user-friendly web-based transportation management platform that enhances service delivery in the logistics industry. Its operations extend throughout the United States, Mexico, and Canada.

Arkose Labs

Series B in 2020
Arkose Labs, Inc. is a technology company specializing in online fraud and abuse prevention for various sectors, including online marketplaces, travel, banking, social media, ticketing, and online gaming. Founded in 2015 and headquartered in San Francisco, California, with an additional location in Brisbane, Australia, the company offers a platform that safeguards consumer actions against threats such as account takeover, fake account abuse, scraping, spam, and gift card fraud. Arkose Labs employs a unique approach that focuses on determining true user intent and addressing attacks in real-time through risk assessments and interactive authentication challenges. By undermining the financial incentives behind fraudulent activities, the platform enhances security and improves customer experiences for businesses in retail, gaming, and fintech industries. Recognized by Gartner as a 2020 Cool Vendor, Arkose Labs aims to provide long-term protection while maintaining effective customer throughput.

Silverback Therapeutics

Series B in 2020
Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing tissue-targeted therapeutics for cancer, chronic viral infections, and other serious diseases. The company's lead product candidate, SBT6050, is currently in a Phase I/Ib clinical trial. It is a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody, specifically targeting tumors such as breast, gastric, and non-small cell lung cancers. Additionally, Silverback is advancing SBT6290, a preclinical candidate that targets Nectin4, expressed in various cancers, and SBT8230, aimed at treating chronic hepatitis B virus infection. Utilizing its proprietary ImmunoTAC technology, Silverback aims to develop a new generation of therapies that can be systemically delivered yet act locally at disease sites, thereby modulating critical disease pathways that were previously considered inaccessible.

HealthJoy

Series C in 2020
HealthJoy is a first-of-its-kind benefits experience platform helping companies save money while improving employee satisfaction. Through personalized guidance and AI technology, we empower employees to better use and understand their benefits. The result is happier employees, increased cost containment, and fewer questions for HR. HealthJoy integrates a client’s existing benefits to deliver each employee a personalized digital benefits wallet that keeps benefits top-of-mind. Employees also gain on-demand access to online medical consultations, live healthcare concierges, Rx savings, and much more. HealthJoy empowers employees to become educated healthcare shoppers and fundamentally changing the dynamics of healthcare.

Epsagon

Series A in 2020
Epsagon is a developer of a SaaS platform designed to enhance performance monitoring and troubleshooting for serverless and microservice applications. Founded in 2017 and headquartered in Tel Aviv, Israel, Epsagon provides Dev and Ops teams with automated data correlation, payloads, and comprehensive observability across various environments, including containers, virtual machines, and serverless architectures. Its lightweight agent SDK enables automated instrumentation and tracing, ensuring full visibility without the need for extensive training, manual coding, or maintenance. The platform aims to reduce application downtime, accelerate feature deployment, and streamline the process of identifying and resolving issues, ultimately helping organizations optimize costs and improve engineering efficiency.

ShiraTronics

Series A in 2019
ShiraTronics is in the early stages of developing new innovative therapies to combat debilitating migraine headaches. The company is focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians. ShiraTronics is the first spinout from NuXcel a global medical device accelerator company.

Kenna Security

Series D in 2019
Kenna Security, Inc. is a technology company specializing in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, the company offers the Kenna platform, which enables organizations to prioritize vulnerabilities, measure risk, and automate analysis. By utilizing Cyber Risk Context Technology, Kenna helps clients focus on critical cyber risks, thereby enhancing the efficiency of security teams. Its solutions cater to a diverse range of sectors, including media and entertainment, healthcare, telecommunications, financial services, and more, both domestically and internationally. Kenna Security has established itself as a leader in predictive cyber risk management, serving numerous Fortune 100 companies across various industries.

Primary

Series C in 2019
Primary is making better clothes for kids and building a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

Edgewise Therapeutics

Series B in 2019
Edgewise Therapeutics is a clinical-stage biopharmaceutical company based in Boulder, Colorado, specializing in the development of small molecule therapies for severe musculoskeletal diseases. Founded in 2017, the company leverages its expertise in skeletal muscle physiology to create innovative treatments for genetically defined muscle disorders, including Duchenne, Becker, and limb girdle muscular dystrophies. Edgewise Therapeutics employs a precision medicine platform to identify and target key muscle proteins and modulators, aiming to address the underlying causes of these conditions. Additionally, the company has established a state-of-the-art research facility to enhance its capabilities in understanding muscle adaptation and injury related to disease.

Luma Health

Series B in 2019
Luma Health Inc. is a San Francisco-based company founded in 2015 that specializes in developing a patient engagement platform designed to enhance the connection between patients and healthcare providers. The platform facilitates smart scheduling, referral management, and appointment reminders, as well as mobile patient intake and care pathways. It also supports patient communications and integrates with electronic health records (EHR) while providing insights and analytics. By focusing on modern, mobile-first solutions, Luma Health aims to improve the patient experience and optimize appointment utilization for healthcare providers and health systems.

Entelo

Venture Round in 2019
Entelo applies intelligence to big data to help modern recruiters find, qualify, and acquire talent. Today over 600 customers of all sizes and industries trust Entelo to provide their talent acquisition teams with higher candidate engagement, actionable insights, and increased productivity. To learn how leading companies such as Capital One, Cisco, Facebook, GE, Genentech, Netflix, Northrop Grumman, and Target are building their organizations using Entelo, visit www.entelo.com.

Rimeto

Series A in 2019
Rimeto LLC, founded in 2016 and based in San Francisco, California, specializes in developing application and system software that enhances workplace collaboration through detailed employee directories and profiles. The company aims to improve access to information within organizations, enabling employees to connect more effectively with their colleagues and tap into collective knowledge. Rimeto's platform integrates data from various enterprise systems, creating a custom-built directory that consolidates information about people, projects, and teams. By leveraging both public and proprietary data sets, Rimeto provides clients with a powerful tool that enhances organizational transparency and facilitates better communication and collaboration, ultimately fostering a more connected work environment. As of June 2020, Rimeto operates as a subsidiary of Slack Technologies.

Cleave Therapeutics

Series C in 2019
Cleave Therapeutics, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2010. The company specializes in developing novel small-molecule drugs that target valosin-containing protein and other protein-degradation pathways critical for the survival of cancer cells. By focusing on these mechanisms, Cleave Therapeutics aims to create enzyme inhibitors that can effectively treat cancer and neurodegenerative diseases. Its research efforts are directed toward discovering innovative therapies that may improve patient outcomes in oncology.

Human Interest

Series B in 2019
Human Interest offers easy and affordable employee retirement plans. Previously, only large companies offered employee retirement plans, leaving more than half of all working Americans without a path to a secure financial future. The company believes that a path to financial independence should be accessible to people in all lines of work.

Omada Health

Series D in 2019
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).

Dstillery

Series D in 2019
Dstillery, Inc. is a digital intelligence platform that specializes in custom audience solutions for brands and their media partners. Founded in 2008 and based in New York, the company offers a range of marketing solutions designed to enhance brand awareness, consideration, and customer retention. Dstillery's premier product, Custom AI Audiences, utilizes tailored artificial intelligence models to deliver accurate and scalable audience targeting. The platform integrates mobile location insights with desktop behaviors, optimizing marketing efforts across various channels, including mobile, desktop, and video. Dstillery also provides geospatial insights through its Dscover Maps tool, allowing brands to analyze market composition by geography. The company serves a diverse clientele across multiple sectors, including retail, finance, and technology, helping them leverage customer data to drive revenue growth and improve audience engagement.

Percepto

Series A in 2019
Percepto is a developer of autonomous drone technology for inspection and surveillance. Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier to making them a must-have platform is the ability of drones to perform tasks autonomously. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Happy Returns

Venture Round in 2019
Happy Returns, Inc. provides in-person returns for online shoppers. It develops a network of Return Bars, kiosks, that enables shoppers to return items in-person and get an immediate refund. The company then ships the item back to the e-commerce companies. The company was founded in 2015 and is based in Santa Monica, California.

HealthJoy

Series B in 2019
HealthJoy is a first-of-its-kind benefits experience platform helping companies save money while improving employee satisfaction. Through personalized guidance and AI technology, we empower employees to better use and understand their benefits. The result is happier employees, increased cost containment, and fewer questions for HR. HealthJoy integrates a client’s existing benefits to deliver each employee a personalized digital benefits wallet that keeps benefits top-of-mind. Employees also gain on-demand access to online medical consultations, live healthcare concierges, Rx savings, and much more. HealthJoy empowers employees to become educated healthcare shoppers and fundamentally changing the dynamics of healthcare.

Nuvaira

Series E in 2019
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Medigate

Series A in 2019
Medigate owns and operates a medical device security platform that protects all connected medical devices on health care provider networks. The platform offers threat detection and attack prevention services. Itay Kirshenbaum, Jonathan Langer, and Pini Pinhasov founded Medigate on September 1, 2017. It has its headquarters in New York City.

Cato Networks

Series C in 2019
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform designed for modern enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in multiple global locations, the company offers an integrated networking and security solution that connects enterprise locations, users, and data securely. Cato's platform includes features such as WAN optimization, firewall protection, secure web gateways, threat protection, and unified communications optimization. It facilitates secure remote access, last mile management, and site deployment, catering to the needs of distributed, mobile, and cloud-enabled organizations. By eliminating traditional branch appliances and reducing MPLS costs, Cato Networks enhances performance across global locations and cloud applications, ensuring secure internet access for users everywhere.

HighLife

Series B in 2019
HighLife SAS is a medtech company that specializes in developing a novel transcatheter mitral valve replacement system aimed at treating patients with mitral regurgitation. Founded in 2010 and headquartered in Paris, France, with an additional office in Irvine, California, the company focuses on providing a minimally invasive prosthetic mitral valve that can be implanted on a beating heart. This approach preserves the native valve structure and respects the surrounding anatomy, ensuring reduced trauma during surgical procedures. HighLife's technology is designed for ease and safety of use, as well as optimal treatment outcomes, allowing for delivery through a transseptal passage via the femoral vein. The system is currently undergoing clinical evaluation to assess its effectiveness in addressing severe heart conditions.

Ribon Therapeutics

Series B in 2019
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.

NeoChord

Series D in 2018
NeoChord, Inc. is a medical technology company that specializes in developing devices to address degenerative mitral valve disease (DMR), a condition that can lead to serious complications such as atrial fibrillation and congestive heart failure. The company's flagship product is the NeoChord Artificial Chordae Delivery System, a disposable device designed to repair damaged heart chordae through a small incision while the heart continues to beat. This innovative approach allows for mitral valve repair to be performed via a 2 to 3-inch incision between the ribs, significantly less invasive than traditional methods that require larger incisions and the use of heart-lung machines. Founded in 2007, NeoChord is headquartered in St. Louis Park, Minnesota.

ZypMedia

Series C in 2018
Zypmedia provides local ad sales executives and their customers an opportunity to grow their business and evolve with a changing media environment. ZypMedia is a full-stack digital advertising technology platform that combines the power of machine learning with the intelligence of human experts to specialize in local-focused advertising. The company's innovative, intelligent tools enable you to bridge the audience gap between traditional and digital worlds, expand your offerings to better reach your local audience, and significantly grow your revenue.

Arkose Labs

Series A in 2018
Arkose Labs, Inc. is a technology company specializing in online fraud and abuse prevention for various sectors, including online marketplaces, travel, banking, social media, ticketing, and online gaming. Founded in 2015 and headquartered in San Francisco, California, with an additional location in Brisbane, Australia, the company offers a platform that safeguards consumer actions against threats such as account takeover, fake account abuse, scraping, spam, and gift card fraud. Arkose Labs employs a unique approach that focuses on determining true user intent and addressing attacks in real-time through risk assessments and interactive authentication challenges. By undermining the financial incentives behind fraudulent activities, the platform enhances security and improves customer experiences for businesses in retail, gaming, and fintech industries. Recognized by Gartner as a 2020 Cool Vendor, Arkose Labs aims to provide long-term protection while maintaining effective customer throughput.

Raken

Series A in 2018
Raken provides mobile-first technology to streamline field workflows for the construction industry. Raken's digital toolbox connects the field to the office with daily reports, time cards, toolbox talks, photo management, production tracking and more. Swinerton Renewable Energy, John W. Danforth, Broadway Mechanical and thousands of other top general contractor and subcontractor firms use Raken for their field reporting needs. To find out more, visit www.rakenapp.com.

Luma Health

Series A in 2018
Luma Health Inc. is a San Francisco-based company founded in 2015 that specializes in developing a patient engagement platform designed to enhance the connection between patients and healthcare providers. The platform facilitates smart scheduling, referral management, and appointment reminders, as well as mobile patient intake and care pathways. It also supports patient communications and integrates with electronic health records (EHR) while providing insights and analytics. By focusing on modern, mobile-first solutions, Luma Health aims to improve the patient experience and optimize appointment utilization for healthcare providers and health systems.

Inari Medical

Series C in 2018
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Kenna Security

Series C in 2018
Kenna Security, Inc. is a technology company specializing in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, the company offers the Kenna platform, which enables organizations to prioritize vulnerabilities, measure risk, and automate analysis. By utilizing Cyber Risk Context Technology, Kenna helps clients focus on critical cyber risks, thereby enhancing the efficiency of security teams. Its solutions cater to a diverse range of sectors, including media and entertainment, healthcare, telecommunications, financial services, and more, both domestically and internationally. Kenna Security has established itself as a leader in predictive cyber risk management, serving numerous Fortune 100 companies across various industries.

Luminate Security

Series A in 2018
Luminate Security Ltd. operates a software-as-a-service security platform designed to enable secure access management for corporate resources from any device. Founded in 2016 and based in Tel Aviv, Israel, Luminate supports the implementation of a Zero Trust Application Access architecture, allowing IT teams to connect users to corporate applications while minimizing the attack surface and enhancing visibility and compliance. The platform integrates seamlessly with cloud infrastructure and on-premises data center technologies, employing Software-Defined Perimeter principles to ensure resources remain hidden from public access. Access is granted through a trust broker, where users undergo authentication and authorization prior to application usage. The agentless Luminate Secure Access Cloud can be deployed in under five minutes, providing comprehensive visibility of user actions and facilitating governance and risk mitigation for corporate resources. As of February 2019, Luminate Security operates as a subsidiary of NortonLifeLock Inc.

Intuity Medical

Debt Financing in 2018
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution for millions of patients who need to regularly test their blood glucose. The company was founded in 2002 and is headquartered in Fremont, California.

Happy Returns

Series B in 2017
Happy Returns, Inc. provides in-person returns for online shoppers. It develops a network of Return Bars, kiosks, that enables shoppers to return items in-person and get an immediate refund. The company then ships the item back to the e-commerce companies. The company was founded in 2015 and is based in Santa Monica, California.

imperva

Series B in 2017
Imperva, Inc. is a cybersecurity company that specializes in protecting critical data and applications across cloud and on-premises environments. Founded in 2002 and headquartered in Redwood Shores, California, Imperva offers a range of solutions, including the SecureSphere product line, which provides security for databases, files, and web applications. This product helps organizations manage data risk and comply with regulatory requirements. Additionally, Imperva's Incapsula service offers cloud-based website security, distributed denial-of-service protection, and load balancing to enhance website performance and security. Other offerings include ThreatRadar for security intelligence, CounterBreach for protecting enterprise data from various threats, and Camouflage Data Masking for safeguarding sensitive information during development and testing. Imperva serves a diverse clientele, including banks, retailers, technology firms, and government agencies, through a network of distributors and resellers.

Neuros Medical

Series A in 2017
Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies to address unmet medical needs for patients globally. The company’s flagship technology, Electrical Nerve Block, targets the elimination of chronic pain associated with various conditions, including neuroma, residual limb pain, chronic post-surgical pain, and chronic migraines. Additionally, Neuros Medical offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices designed to enhance treatment outcomes. Founded in 2008, the company aims to provide innovative solutions for chronic pain management.

Okami Medical

Series B in 2017
Okami Medical, Inc. specializes in the manufacturing and supply of medical devices designed for the occlusion of peripheral vessels. The company's flagship product, the LOw-profile Braided Occluder (LOBO), provides interventional physicians with a versatile solution for occluding various arterial targets without the need for multiple embolic devices. The LOBO system features a patented design and proprietary HDBRAID technology, which creates a highly occlusive pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011 and headquartered in Aliso Viejo, California, Okami Medical was established to meet the evolving needs of patients and physicians by developing innovative and reliable medical devices for vessel occlusion.

Inceptus Medical

Series B in 2017
Inceptus is a medical device company incubator with a mission to create and foster innovative concepts into companies by providing a combination of experienced engineering, clinical research expertise, seasoned leadership and strong financial resources. The Inceptus team includes talented medical device engineers, serial entrepreneurs, executive managers and investors with a successful track record in the formation of medical device companies.

Effector Therapeutics

Series C in 2017
Effector Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2012. The company specializes in the discovery and development of small molecule drugs designed to treat cancer and other serious diseases by selectively regulating protein synthesis, specifically targeting mRNA translation. Effector Therapeutics focuses on developing translation regulators that inhibit disregulated translation, which is crucial for tumor growth and survival. This innovative approach aims to provide potent and selective therapeutic options, offering a promising avenue for delivering new cancer treatments to patients in need.

Primary

Series B in 2017
Primary is making better clothes for kids and building a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

Entelo

Series C in 2017
Entelo applies intelligence to big data to help modern recruiters find, qualify, and acquire talent. Today over 600 customers of all sizes and industries trust Entelo to provide their talent acquisition teams with higher candidate engagement, actionable insights, and increased productivity. To learn how leading companies such as Capital One, Cisco, Facebook, GE, Genentech, Netflix, Northrop Grumman, and Target are building their organizations using Entelo, visit www.entelo.com.

Omada Health

Series C in 2017
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).

HelloSign

Series B in 2017
HelloSign is a technology company that provides fast, secure, and legally binding eSignature solutions, along with digital workflow and eFax services. The platform is designed to streamline business transactions for a diverse range of users, from small startups to large enterprises, making it easier to manage and automate important processes. Trusted by millions of individuals and over 60,000 companies worldwide, HelloSign prioritizes user experience and innovation in its mission to simplify work and improve efficiency in business operations.

Route 92

Venture Round in 2017
Route 92 Medical, Inc. specializes in developing innovative medical devices aimed at treating acute ischemic stroke and related conditions. The company has created a stealthy catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery system. These products are designed to assist healthcare professionals in effectively treating strokes and enhancing patient recovery. Founded in 2015 and based in San Mateo, California, Route 92 Medical continues to focus on advancing technologies that improve outcomes for stroke patients.

Chute

Series B in 2017
Chute Corporation, founded in 2011 and based in San Francisco, specializes in visual marketing automation. The company offers a platform that enables marketers to discover, organize, and publish user-generated content, specifically fan photos and videos. This platform supports various touchpoints, including mobile apps, photo galleries, and advertising displays. Chute also provides a Capture app that allows brands to source real-time images from employees and ambassadors on iOS and Android devices. By leveraging visual recognition, geolocation, and text search, Chute empowers agencies, publishers, and brands to curate content while gaining valuable insights into consumer engagement and influencer effectiveness. Through its services, the company facilitates the collection of user data, enhancing marketing strategies and campaign effectiveness.

HotelTonight

Series E in 2017
HotelTonight, Inc. is a mobile application designed specifically for booking last-minute hotel deals, allowing users to secure same-day accommodations through their smartphones and tablets. Founded in 2010 and headquartered in San Francisco, California, the platform serves as a marketplace for hotels to fill unsold rooms that would otherwise go unoccupied. It offers competitive pricing for bookings made up to seven days in advance, catering to business travelers, leisure travelers, and locals. As of April 2019, HotelTonight operates as a subsidiary of Airbnb, Inc.

Kenna Security

Series B in 2016
Kenna Security, Inc. is a technology company specializing in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, the company offers the Kenna platform, which enables organizations to prioritize vulnerabilities, measure risk, and automate analysis. By utilizing Cyber Risk Context Technology, Kenna helps clients focus on critical cyber risks, thereby enhancing the efficiency of security teams. Its solutions cater to a diverse range of sectors, including media and entertainment, healthcare, telecommunications, financial services, and more, both domestically and internationally. Kenna Security has established itself as a leader in predictive cyber risk management, serving numerous Fortune 100 companies across various industries.

Inspire Medical Systems

Series F in 2016
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

Intuity Medical

Venture Round in 2016
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution for millions of patients who need to regularly test their blood glucose. The company was founded in 2002 and is headquartered in Fremont, California.

Pluto TV

Series B in 2016
Pluto TV is a free streaming television service that offers over 100 live channels and a vast library of on-demand movies. Founded in 2013 and headquartered in Los Angeles, California, the platform partners with major television networks, movie studios, publishers, and digital media companies to provide a diverse range of content, including news, sports, lifestyle programming, cartoons, and trending digital series. Accessible via mobile apps, web browsers, and connected TV devices, Pluto TV attracts millions of viewers each month, making it a leading choice for free entertainment in the United States. As a subsidiary of Viacom International Inc., Pluto TV continues to expand its offerings and reach a broad audience.

SentreHEART

Series D in 2016
SentreHEART, Inc., based in Redwood City, California, is a privately held medical device company that manufacturers the LARIAT Suture Delivery Device for remote delivery of a pre-tied suture loop. Innovation in catheter and suture delivery technology enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind. Regulatory clearance for soft tissue ligation and approximation has been received in the US, Europe, and Canada.

Cato Networks

Series B in 2016
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform designed for modern enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in multiple global locations, the company offers an integrated networking and security solution that connects enterprise locations, users, and data securely. Cato's platform includes features such as WAN optimization, firewall protection, secure web gateways, threat protection, and unified communications optimization. It facilitates secure remote access, last mile management, and site deployment, catering to the needs of distributed, mobile, and cloud-enabled organizations. By eliminating traditional branch appliances and reducing MPLS costs, Cato Networks enhances performance across global locations and cloud applications, ensuring secure internet access for users everywhere.

Electric Cloud

Series F in 2016
Electric Cloud, Inc. specializes in developing release automation and continuous delivery software for a diverse range of industries, including financial services, automotive, and embedded systems. Founded in 2002 and based in San Jose, California, the company offers products such as ElectricFlow, a release orchestration platform that enables teams to manage releases efficiently, and Electric Accelerator, which enhances build and testing processes by distributing workloads across various resources. Electric Cloud's solutions help organizations like Cisco, GE, and Intel improve their DevOps productivity and streamline their software delivery processes. By automating manual tasks and reducing the risks associated with software releases, the company empowers development teams to accelerate time-to-market and enhance software quality. As of April 2019, Electric Cloud operates as a subsidiary of CloudBees, Inc.

Cleave Therapeutics

Series B in 2016
Cleave Therapeutics, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2010. The company specializes in developing novel small-molecule drugs that target valosin-containing protein and other protein-degradation pathways critical for the survival of cancer cells. By focusing on these mechanisms, Cleave Therapeutics aims to create enzyme inhibitors that can effectively treat cancer and neurodegenerative diseases. Its research efforts are directed toward discovering innovative therapies that may improve patient outcomes in oncology.

Apptimize

Series B in 2016
Apptimize Inc. develops a mobile A/B testing platform for iOS and Android applications. The company’s platform helps users through instant updates and actionable insights identifying the optimal user experience. It offers cross-platform optimization across all channels including web, mobile, mobile web, OTT, and in-store. Apptimize Inc. was founded in 2013 and is based in San Francisco, California. As of August 27, 2019, Apptimize Inc. operates as a subsidiary of Airship, Inc.

Appthority

Series B in 2016
Appthority, Inc. specializes in mobile application security solutions, focusing on protecting enterprises from mobile threats that jeopardize data privacy and employee security. Founded in 2011 and based in San Francisco, California, Appthority has established itself as a leader in the Mobile Threat Defense sector. The company's flagship product, the Mobile Threat Protection (MTP) solution, provides comprehensive protection against risks associated with mobile devices, applications, and networks. Appthority is trusted by numerous Fortune 1000 companies for its ability to deliver effective mobile threat protection while offering enhanced visibility and control over mobile risks. As a subsidiary of NortonLifeLock Inc. since November 2018, Appthority continues to prioritize the security of enterprise data and the productivity of employees.

Primary

Series A in 2016
Primary is making better clothes for kids and building a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

ZEFR

Series E in 2016
ZEFR is a video advertising company that specializes in creating targeted video ad placements through its proprietary technology. The company offers custom packages that combine advanced technology with human review to select individual videos, enabling brands to effectively and safely scale their video ad campaigns. ZEFR has access to extensive data that surpasses that of any other YouTube partner, allowing it to drive improved results for content owners and brands alike. Through its innovative approach, ZEFR aims to enhance the effectiveness of video advertising while honoring the spirit of creativity and boundary-pushing that characterized the original Zephyr skate team in Venice.

Ribon Therapeutics

Series A in 2016
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.